NOVARTIS AG (NVSEF)
Clinical trial NCT07517250 updates: 1. completion date: 2027-03-03 → 2026-12-03 2. primary completion date: 2027-03-03 → 2026-12-03
Clinical trial NCT07517250 updates: 1. completion date: 2027-03-03 → 2026-12-03 2. primary completion date: 2027-03-03 → 2026-12-03
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical